Increase in the duration of antidepressant treatment from 1994 to 2003: A nationwide population-based study from Finland

Pharmacoepidemiology and Drug Safety

Volumn 19, Issue 11, 2010, Pages 1186-1193

  Sihvo, Sinikka ^a   Wahlbeck, Kristian ^a,b   McCallum, Alison ^c   Sevon, Tiina ^a   Arffman, Martti ^a   Haukka, Jari ^a   Keskimäki, Ilmo ^a,d   Hemminki, Elina ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b VAASA CENTRAL HOSPITAL   (Finland)

^c NHS LOTHIAN   (United Kingdom)

^d UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Antidepressants; Medication persistence; Pharmacoepidemiology

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CITALOPRAM; HYPNOTIC AGENT; PAROXETINE; PSYCHOTROPIC AGENT; SEDATIVE AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; FINLAND; HUMAN; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MALE; MENTAL HEALTH CARE; PATIENT CARE; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIST; REGISTER; REIMBURSEMENT; TREATMENT DURATION;

ADULT; ANTIDEPRESSIVE AGENTS; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MENTAL DISORDERS; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; PREVALENCE; REGISTRIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 78049297491     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2017     Document Type: Article

References (29)

1. National Agency for Medicines and Social Insurance Institution, 2009. Finnish Statistics on Medicines 2008. Helsinki. online access:
2. Henriksson S, Boethius G, Håkansson J, Isacsson G. Indications for and outcome of antidepressant medication in a population: a prescription database and medical record study, in Jämtland county, Sweden, 1995. Acta Psychiatr Scand 2003; 108: 427-431.
3. Trifirò G, Barbui C, Spina E, et al. Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. Pharmacoepidemiol Drug Saf 2007; 16: 552-559.
4. Sihvo S, Isometsä E, Kiviruusu O, et al. Antidepressant utilisation patterns and determinants of short-term and non-psychiatric use in the Finnish population. J Affect Disord 2008; 110: 94-105.
5. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. Am J Psychiatry 2000; 57(supp l4): 1-45. online access:
6. NICE (National Institute for Health and Clinical Excellence). Depression (amended) Management of depression in primary and secondary care. NICE Clinical Guide 2007, 23 (amended). online access:
7. Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003; 361: 653-661.
8. Balwin DS, Anderson IM, Nutt DJ, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2005; 19: 567-596.
9. American Psychiatric Association. Practice guidelines for the treatment of patients with panic disorder. Am J Psychiatry 1998; 155(suppl 5): 1-34.
10. NICE (National Institute for Health and Clinical Excellence). Anxiety. Management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. Clinical Guideline 22. online access: 2004.
11. Olfson M, Marcus SC, Tedeschi M, Wan GJ. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry 2006; 163: 101-108.
12. Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Sokero PT, Isometsä ET. Continuity is the main challenge in treating major depressive disorder in psychiatric care. J Clin Psychiatry 2005; 66: 220-227.
13. Vos T, Haby MM, Barendregt JJ, Kruijshaar M, Corry J, Andrews G. The burden of major depression avoidable by longer-term treatment strategies. Arch Gen Psychiatry 2004; 61: 1097-1103.
14. Hansen DG, Vach W, Rosholm J-E, Sondergaard J, Gram LF, Kragstrup J. Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics. Fam Pract 2004; 21: 623-629.
15. Meijer WE, Heerdink ER, Leufkens HG, Herings RM, Egberts AC, Nolen WA. Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol 2004; 60: 57-61.
16. Kajantie M, Manderbacka K, McCallum A, et al. How to carry out register-based health services research in Finland? Compiling complex study data in the REDD project. STAKES, Discussion Papers 1/2006, Helsinki 2006.
17. Sevon T. Tilastollinen analyysi masennuslääkkeiden käytön yleisyydelle ja hoitosuosituksen toteutumiselle. [Statistical analysis on antidepressant utilisation prevalence and implementation of practice guidelines, in Finnish only], Master Thesis, Department of Mathematics and Statistics, University of Helsinki, 2007.
18. Van Wijk BLG, Klungel OH, Heerdink ER, de Boer A. Refill persistence with chronic medication assessed form a pharmacy database was influences by a method of calculation. J Clin Epidemiol 2006; 59: 11-17.
19. Moore M, Yuen HM, Dunn N, Mullee MA, Maskell J, Kendrick T. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. Br Med J 2009; 339: b3999.: 10.1136/bmj.b3999
20. Bosmans JE, Hermens MLM, de Bruijne MC, et al. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression. J Affect Disord 2008; 111: 106-112.
21. Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psych 1998; 55: 1128-1132.
22. Liljakumpu T, Hartikainen S, Klaukka T, Koponen H, Kivelä S.-L, Isoaho R. Psychotropics among the home dwelling elderly - increasing trends. Int J Geriatr Psychiatry 2002; 17: 874-883.
23. Curtis LH, Østbye T, Sendersky V, et al. Inappropriate prescribing for the elderly Americans in a large outpatient population. Arch Intern Med 2004; 164: 1621-1625.
24. Percudani M, Barbui C, Fortino I, Petrovich L. Antidepressant drug prescribing among elderly subjects: a population-based study. Int J Geriatr Psychiatry 2005; 20: 113-118.
25. Sorvaniemi M, Alho A, Hohtari-Kivimäki U, et al. Improved detection and pharmacotherapy of major depression from 1989 to2001 in psychiatric outpatient care in Finland. Nord J Psychiatry 2006; 60: 239-242.
26. Vuorilehto M, Melartin T, Isometsä E. Depressive disorders in primary care: recurrent, chronic, and co-morbid. Psychol Med 2004; 35: 673-682.
27. Kniesner TJ, Powers RH, Croghan TW. Provider type and depression treatment adequacy. Health Policy 2005; 72: 321-332.
28. Autti-Rämö I, Seppänen J, Raitasalo R, Martikainen J, Sourander A. Increase in use of psychotropics among adolescents and young adults since the beginning of the 21st century. [English abstract] Finnish Med J 2009; 64: 477-482.
29. Gardarsdottir H, Souverein PC, Egberts TCG, Heerdink ER. Construction of drug treatment episodes from drug-dispensing histories is influences by the gap length. J Clin Epidemiol 2010; 63: 422-427.